
Aluminium tri-sec-butoxide | CAS:2269-22-9
Aluminium tri-sec-butoxide
- 名称:仲丁醇铝; 三仲丁氧基铝 | Aluminium tri-sec-butoxide
- CAS号:2269-22-9
- 别名:Aluminum sec-butoxide
- 分子式:3(C4H9O).Al
- 分子量:246.32
- EINESC号:218-871-2
产品描述
物理化学性质
水溶性 | 分解 |
---|---|
沸点 | 200-206 ºC (30 mmHg) |
闪点 | 27 ºC |
密度 | 0.967 |
安全数据
危险品标志 | Xi |
---|---|
危险类别码 | R10;R21/22 |
安全说明书 | S16;S26;S36/37/39;S43;S45 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.Priyatham Gorjala et al.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 23(6), 1061-1073 (2010-06-16)
Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung.Andrew P Fontenot et al.Journal of immunology (Baltimore, Md. : 1950), 168(7), 3627-3634 (2002-03-22)
Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.Andrew P Fontenot et al.The Journal of clinical investigation, 110(10), 1473-1482 (2002-11-20)
Gene expression profile in BALB/c-3T3 cells transformed with beryllium sulfate.P Joseph et al.Molecular carcinogenesis, 32(1), 28-35 (2001-09-25)
[Diagnosis of chronic berylliosis].J Schreiber et al.Pneumologie (Stuttgart, Germany), 53(4), 193-198 (1999-07-20)
Upregulation of I-CAM1 in response to beryllium exposure in small airway epithelial cells.Shannan Rodriguez et al.Toxicology letters, 179(3), 140-147 (2008-06-10)
Bis[2-(benz (othia/oxa)zol-2-yl)phenolato-[κ]2N,O] beryllium(II). Tong Y-P. Acta Crystallographica Section E, Structure Reports Online, 61(8), m1472-m1474 (2005)
Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.Chadi H Stephan et al.Journal of applied toxicology : JAT, 29(1), 27-35 (2008-09-13)
Patch testing with beryllium alloy samples in guinea pigs.D Zissu et al.Contact dermatitis, 34(3), 196-200 (1996-03-01)
Proteomic analysis of beryllium-induced genotoxicity in an Escherichia coli mutant model system.Kirsten J Taylor-McCabe et al.Proteomics, 6(5), 1663-1675 (2006-02-01)
Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.S S Tinkle et al.Journal of immunology (Baltimore, Md. : 1950), 163(5), 2747-2753 (1999-08-24)
Comparison of in vivo and in vitro measures of beryllium sensitization.C A Bobka et al.Journal of occupational and environmental medicine, 39(6), 540-547 (1997-06-01)
Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.A P Fontenot et al.Clinical immunology (Orlando, Fla.), 100(1), 4-14 (2001-06-21)
Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.S S Tinkle et al.American journal of respiratory and critical care medicine, 156(6), 1884-1891 (1997-12-31)
The structure and interaction energies of the weak complexes of CHClF2 and CHF3 with HCCH: a test of density functional theory methods.Mark A Vincent et al.Physical chemistry chemical physics : PCCP, 13(10), 4388-4392 (2011-01-20)
The handling of the mechanistic probe 5-fluorouridine by the pseudouridine synthase TruA and its consistency with the handling of the same probe by the pseudouridine synthases TruB and RluA.Marguerite K McDonald et al.Biochemistry, 50(3), 426-436 (2010-12-15)
Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs.Kristin K Nelson et al.The Journal of biological chemistry, 281(20), 14100-14110 (2006-03-30)
Beryllium-specific immune response in primary cells from healthy individuals.Anu Chaudhary et al.Toxicology, 201(1-3), 9-19 (2004-08-07)
Beryllium-stimulated reactive oxygen species and macrophage apoptosis.Richard T Sawyer et al.Free radical biology & medicine, 38(7), 928-937 (2005-03-08)
A neutron diffraction determination of the structure of beryllium sulphate tetrahydrate, BeSO4.4H2O.Sikka SK and Chidambaram R. Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials, 25(2), 310-315 (1969)
Regulation of cytokine gene expression by adjuvants in vivo.P Victoratos et al.Clinical and experimental immunology, 109(3), 569-578 (1997-10-27)
Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c-3T3 cells.N Keshava et al.Molecular and cellular biochemistry, 222(1-2), 69-76 (2001-10-27)
The synergetic effect in beryllium sulfate tetrahydrate-an experimental electron-density study.Kellersohn T, et al. Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials, 50(3), 316-326 (1994)
The carcinogenicity of beryllium. Kuschner M. Environmental Health Perspectives, 40, 101-101 (1981)
Beryllium-induced disturbances of the murine immune system reflect some phenomena observed in sarcoidosis.S Pfeifer et al.International archives of allergy and immunology, 104(4), 332-339 (1994-08-01)
Beryllium alters lipopolysaccharide-mediated intracellular phosphorylation and cytokine release in human peripheral blood mononuclear cells.Shannon Silva et al.Journal of occupational and environmental hygiene, 6(12), 775-782 (2009-11-07)
Patch tests with beryllium salts.Andreas J Bircher Contact dermatitis, 64(6), 363-364 (2011-05-14)
Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.A P Fontenot et al.Proceedings of the National Academy of Sciences of the United States of America, 97(23), 12717-12722 (2000-10-26)
Hydration of beryllium(II) in aqueous solutions of common inorganic salts. A combined vibrational spectroscopic and ab initio molecular orbital study.Wolfram W Rudolph et al.Dalton transactions (Cambridge, England : 2003), (33)(33), 6513-6527 (2009-08-13)
Novel in vitro method for identification of individuals at risk for beryllium hypersensitivity.E A Ojo-Amaize et al.Clinical and diagnostic laboratory immunology, 1(2), 164-171 (1994-03-01)
Inhibition of normal human lung fibroblast growth by beryllium.N M Lehnert et al.Toxicology, 160(1-3), 119-127 (2001-03-14)
Refinement of the crystal structure of beryllium sulphate tetrahydrate.Dance IG and Freeman HC. Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials, 25(2), 304-310 (1969)
Divergent effect of cobalt and beryllium salts on the fate of peripheral blood monocytes and T lymphocytes.Fabiana Paladini et al.Toxicological sciences : an official journal of the Society of Toxicology, 119(2), 257-269 (2010-10-27)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!